Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Should not yet change clinical management of ischemia-reperfusion; leaves open whether B2-targeted modulation improves outcomes in prospective trials.
Baxter et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: